Prelude Therapeutics, Inc. (PRLD)
2.885
+0.04
(+1.58%)
USD |
NASDAQ |
Dec 31, 16:00
2.885
0.00 (0.00%)
After-Hours: 18:50
Prelude Therapeutics Market Cap: 181.37M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 19.40B |
| Protalix Biotherapeutics, Inc. | 144.36M |
| Relay Therapeutics, Inc. | 1.472B |
| ALX Oncology Holdings, Inc. | 61.54M |
| Immunome, Inc. | 1.972B |
Market Cap Related Metrics
| PS Ratio | 19.46 |
| Price to Book Value | 3.099 |
| Price | 2.885 |
| Earnings Yield | -55.92% |